Selection of non-small cell lung cancer patients for intercalated chemotherapy and tyrosine kinase inhibitors
, , , y
18 jul 2017
Acerca de este artículo
Categoría del artículo: Review
Publicado en línea: 18 jul 2017
Páginas: 241 - 251
Recibido: 03 may 2017
Aceptado: 09 jun 2017
DOI: https://doi.org/10.1515/raon-2017-0029
Palabras clave
© 2017 Matjaz Zwitter, Antonio Rossi, Massimo Di Maio, Maja Pohar Perme, Gilberto Lopes
This work is licensed under the Creative Commons Attribution 4.0 International License.
Zwitter, Matjaz
Institute of Oncology LjubljanaLjubljana, Slovenia
Faculty of Medicine, University of MariborMaribor, Slovenia
Rossi, Antonio
Division of Medical Oncology, IRCCS Casa Sollievo della Sofferenza HospitalSan Giovanni Rotondo (FG), Italy
Di Maio, Massimo
Division of Medical Oncology, Mauriziano Hospital, Oncology Department, University of TurinTorino, Italy
Perme, Maja Pohar
Institute for Biostatistics and Medical Informatics, Faculty of Medicine, University of LjubljanaLjubljana, Slovenia
Lopes, Gilberto
Centro Paulista de Oncologia e HCor Onco, members of the Oncoclinicas do Brasil Group, Sao Paulo, Brazil and Sylvester Comprehensive Cancer Center, University of MiamiMiami, FL, USA